LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

Search

West Pharmaceutical Services Inc

Închisă

SectorSănătate

269.3 1.04

Rezumat

Modificarea prețului

24h

Curent

Minim

264

Maxim

275.31

Indicatori cheie

By Trading Economics

Venit

8.2M

140M

Vânzări

38M

804M

P/E

Medie Sector

40.335

76.798

EPS

1.96

Randament dividend

0.31

Marjă de profit

17.406

Angajați

10,600

EBITDA

19M

217M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+30.87% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.31%

2.37%

Data viitoare de dividende

4 feb. 2026

Următoarea dată ex-dividende

28 ian. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-209M

20B

Deschiderea anterioară

268.26

Închiderea anterioară

269.3

Sentimentul știrilor

By Acuity

50%

50%

159 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 dec. 2025, 23:50 UTC

Acțiuni populare

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

17 dec. 2025, 23:20 UTC

Câștiguri

Correction to Micron Logs Sales Jump Article

17 dec. 2025, 23:07 UTC

Câștiguri

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

17 dec. 2025, 21:37 UTC

Câștiguri

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

17 dec. 2025, 23:53 UTC

Market Talk

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

17 dec. 2025, 23:43 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

17 dec. 2025, 23:06 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

17 dec. 2025, 23:05 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

17 dec. 2025, 23:04 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

17 dec. 2025, 23:03 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

17 dec. 2025, 23:02 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

17 dec. 2025, 22:59 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

17 dec. 2025, 22:57 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

17 dec. 2025, 22:56 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

17 dec. 2025, 22:55 UTC

Achiziții, Fuziuni, Preluări

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

17 dec. 2025, 22:49 UTC

Market Talk

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

17 dec. 2025, 21:58 UTC

Câștiguri

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dec. 2025, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

17 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 dec. 2025, 21:46 UTC

Câștiguri

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

17 dec. 2025, 21:20 UTC

Câștiguri

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dec. 2025, 21:10 UTC

Câștiguri

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

17 dec. 2025, 21:05 UTC

Câștiguri

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

17 dec. 2025, 21:04 UTC

Câștiguri

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

17 dec. 2025, 21:04 UTC

Câștiguri

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

17 dec. 2025, 21:03 UTC

Câștiguri

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

17 dec. 2025, 21:03 UTC

Câștiguri

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

17 dec. 2025, 21:03 UTC

Câștiguri

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

17 dec. 2025, 21:02 UTC

Câștiguri

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

17 dec. 2025, 21:01 UTC

Câștiguri

Micron Technology 1Q Rev $13.64B >MU

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

30.87% sus

Prognoză pe 12 luni

Medie 348.7 USD  30.87%

Maxim 375 USD

Minim 285 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

10

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

159 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat